There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests
via jamanetwork.com
Short excerpt below. Read at the original source.
The popularity of GLP-1 weight-loss medications continues to soar—and their uptake is helping to push down obesity rates on a national scale—but a safe, evidence-based way off the drugs isn’t yet in clear view. An analysis published this week in JAMA Internal Medicine found that most participants in a clinical trial who were assigned to […]